...
首页> 外文期刊>Microbial drug resistance: MDR : Mechanisms, epidemiology, and disease >BmeRABC5 is a multidrug efflux system that can confer metronidazole resistance in Bacteroides fragilis.
【24h】

BmeRABC5 is a multidrug efflux system that can confer metronidazole resistance in Bacteroides fragilis.

机译:BmeRABC5是一种多药外排系统,可在脆弱拟杆菌中赋予甲硝唑抗性。

获取原文
获取原文并翻译 | 示例
           

摘要

The RND-family efflux pump gene bmeB5 was previously shown to be overexpressed in metronidazole-resistant laboratory mutants of Bacteroides fragilis. In the present study, we characterized the bmeABC5 genes and an upstream putative TetR-family regulator gene (bmeR5). bmeR5 (645 bp) was located 51 bp upstream of bmeA5 and encoded a 24.9-kDa protein. Deletant strains lacking bmeB5 or bmeR5 were constructed from a wild-type B. fragilis strain ADB77. Strain antimicrobial susceptibility was determined and gene expression was quantified. bmeR5 was overexpressed in Escherichia coli using a 6x-His tag system; BmeR5-His6 was isolated from inclusion bodies and its binding to bmeABC5 promoter regions was determined. BmeR5-His6 bound specifically to the bmeR5-bmeC5 intergenic region (IT1). Deletion of bmeR5 (ADB77DeltabmeR5) resulted in a significant (p < 0.05) increase in expression of bmeA5, bmeB5, and bmeC5, and > two-fold increase in minimum inhibitory concentrations (MICs) of ampicillin, cefoxitin, cefoperazone, ciprofloxacin, imipenem, metronidazole, ethidium bromide, and sodium dodecyl sulfate (SDS). MICs were reduced by the efflux pump inhibitor carbonyl cyanide m-chlorophenyl hydrazone (CCCP). The MICs of ampicillin, cefoperazone, metronidazole, and SDS were reduced by approximately two-fold in ADB77DeltabmeB5. A multidrug (metronidazole)-resistant, nim-negative B. fragilis clinical isolate overexpressed bmeABC5 genes, had a G-->T point mutation in IT1, and significantly reduced binding to BmeR5-His6. These data demonstrate that BmeR5 is a local repressor of bmeABC5 expression and that mutations in IT1 can lead to a derepression and resistance to multiple antimicrobial agents, including metronidazole.
机译:以前显示RND家族外排泵基因bmeB5在脆弱拟杆菌的耐甲硝唑的实验室突变体中过表达。在本研究中,我们表征了bmeABC5基因和上游推定的TetR家族调节基因(bmeR5)。 bmeR5(645 bp)位于bmeA5上游51 bp,编码24.9-kDa蛋白。缺乏bmeB5或bmeR5的缺失菌株是从野生型脆弱脆弱芽孢杆菌ADB77构建的。确定菌株的抗菌药敏性并定量基因表达。使用6x-His标签系统在大肠杆菌中过表达bmeR5;从包涵体中分离出BmeR5-His6,并确定其与bmeABC5启动子区域的结合。 BmeR5-His6专门绑定到bmeR5-bmeC5基因间区域(IT1)。删除bmeR5(ADB77DeltabmeR5)导致bmeA5,bmeB5和bmeC5的表达显着(p <0.05)增加,并且氨苄西林,头孢西丁,头孢哌酮,环丙沙星,亚胺培南的最小抑菌浓度(MIC)增加两倍以上甲硝唑,溴化乙锭和十二烷基硫酸钠(SDS)。通过外排泵抑制剂羰基氰化物间氯苯基((CCCP)可降低MIC。在ADB77DeltabmeB5中,氨苄西林,头孢哌酮,甲硝唑和SDS的MIC降低了约两倍。一种耐多药(甲硝唑),脆弱的尼古拉芽孢杆菌临床分离株过度表达bmeABC5基因,在IT1中具有G-> T点突变,并显着降低了与BmeR5-His6的结合。这些数据表明BmeR5是bmeABC5表达的局部阻遏物,并且IT1中的突变可导致抑制作用和对多种抗菌剂(包括甲硝唑)的抗性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号